ahlam1399
05-28-2015, 11:04 PM
UPDATE 1-Otsuka loses lawsuit challenging FDA approval of generic Abilify
May 28 (Reuters) - Otsuka Pharmaceutical Co Ltd has lost a lawsuit challenging the U.S. Food and Drug Administration's decision to allow generic versions of the company's antipsychotic drug Abilify.http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/46bb5b53/sc/7/mf.gif?resize=1%2C1
http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=zT0iv-PBhZY:JctuonT-znE:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=zT0iv-PBhZY:JctuonT-znE:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=zT0iv-PBhZY:JctuonT-znE:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=zT0iv-PBhZY:JctuonT-znE:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=zT0iv-PBhZY:JctuonT-znE:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/zT0iv-PBhZY
May 28 (Reuters) - Otsuka Pharmaceutical Co Ltd has lost a lawsuit challenging the U.S. Food and Drug Administration's decision to allow generic versions of the company's antipsychotic drug Abilify.http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/46bb5b53/sc/7/mf.gif?resize=1%2C1
http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=zT0iv-PBhZY:JctuonT-znE:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=zT0iv-PBhZY:JctuonT-znE:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=zT0iv-PBhZY:JctuonT-znE:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=zT0iv-PBhZY:JctuonT-znE:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=zT0iv-PBhZY:JctuonT-znE:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/zT0iv-PBhZY